Delphi Ventures

Delphi Ventures is a California-based venture capital and private equity firm founded in 1988 and based in San Mateo. It focuses on life sciences, biotechnology, and healthcare, investing across seed, early-stage, mid-venture, late-venture, and growth opportunities as well as PIPE investments. The firm backs companies in the United States and Canada, with emphasis on medical devices and equipment as well as biotechnology. Its medical devices coverage includes cardiovascular medicine, orthopedics, gynecology, minimally invasive surgery, urology, neurovascular medicine, and next-generation diagnostics. In biotechnology, Delphi typically backs companies after early human clinical data or preclinical efficacy and toxicity studies. Typical investment sizes range from approximately $0.5 million to $12 million, supporting companies through multiple development stages. Delphi Ventures aims to help portfolio companies advance clinical milestones, accelerate commercialization, and grow within the healthcare and life sciences sectors.

James Bochnowski

Founder and Managing Member

David Douglass

General Partner

Donald Lothrop

Partner

Deepa Pakianathan Ph.D

Managing Partner

Deepika R Pakianathan

General Partner

Past deals in Ottawa

Skylock

Seed Round in 2022
Skylock, established in 2022 in Ottawa, Canada, is a post-seed startup specializing in real-time security for decentralized finance (DeFi) protocols. It proactively defends against smart-contract hacks by detecting and blocking malicious transactions, safeguarding assets, and ensuring their safe return to users. Skylock's cutting-edge technology aims to enhance the stability and security of the DeFi industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.